LMR Partners LLP
Institutional investor · Portfolio as of Q3 2020
Top Holdings432 positions
| 183.2M | $1.3B | 26.1% | — | — | 4 qtrssince 2019-Q4 | Unchanged 0 | |
| 131.3M | $781.5M | 16.1% | — | — | 3 qtrssince 2020-Q1 | Increased 85 | |
| 92.6M | $605.7M | 12.5% | — | — | 4 qtrssince 2019-Q4 | Increased 78 | |
| 65M | $153.7M | 3.2% | — | — | 3 qtrssince 2020-Q1 | Increased 90 | |
ALIBABA GROUP HLDG LTD | 430,178 | $122.4M | 2.5% | $202.99 | +36.29% | 2 qtrssince 2020-Q2 | Decreased 0 |
| 117M | $111.8M | 2.3% | — | — | 2 qtrssince 2020-Q2 | Increased 53 | |
HSBC HLDGS PLC SPON ADR NEW | 4M | $77M | 1.6% | $20.20 | -28.85% | 5 qtrssince 2019-Q3 | Increased 47 |
IMMUNOMEDICS INC | 725,957 | $61.7M | 1.3% | — | — | 2 qtrssince 2020-Q2 | Increased 75 |
COSTAR GROUP INC | 72,000 | $61.1M | 1.3% | $59.83 | +41.82% | 4 qtrssince 2019-Q4 | Unchanged 0 |
| 17.5M | $56.1M | 1.2% | — | — | 2 qtrssince 2020-Q2 | Decreased 0 | |
| 47.4M | $53.6M | 1.1% | — | — | 2 qtrssince 2020-Q2 | Increased 47 | |
INFOSYS LTD | 3.5M | $47.9M | 1.0% | $8.80 | +33.71% | 6 qtrssince 2019-Q2 | Decreased 0 |
TAKEDA PHARMACEUTICAL CO LTD | 2.4M | $43.4M | 0.9% | $15.98 | +6.28% | 7 qtrssince 2019-Q1 | Decreased 0 |
Microsoft Corp. | 192,051 | $40.4M | 0.8% | $185.21 | +8.00% | 7 qtrssince 2019-Q1 | Decreased 0 |
| 10.8M | $37.7M | 0.8% | — | — | 4 qtrssince 2019-Q4 | Unchanged 0 | |
| 33.5M | $34.7M | 0.7% | — | — | 4 qtrssince 2019-Q4 | Increased 45 | |
SONY CORP | 453,937 | $34.6M | 0.7% | $15.08 | 0.00% | 1 qtr | New 56 |
BHP GROUP PLC | 805,885 | $34.4M | 0.7% | — | — | 7 qtrssince 2019-Q1 | Increased 45 |
KT CORP SPONSORED ADR | 2.9M | $28.2M | 0.6% | $9.93 | -18.31% | 7 qtrssince 2019-Q1 | Decreased 0 |
SUMITOMO MITSUI FIN GRP INC SPONSORED ADR | 5M | $27.9M | 0.6% | $6.22 | -12.41% | 6 qtrssince 2019-Q2 | Decreased 0 |
LMR Partners LLP manages $4.9B across 432 positions as of Q3 2020. Top holdings: TESLA INC (26.1%), TESLA INC (16.1%), TESLA INC (12.5%). Fund DNA: Diversified Scout. HoldingsIntel Score: 1.5/5.0.
Active quarter - 130 new positions, 280 exits, 54 increased. Top move: IMMU (INCREASED, conviction 75). Portfolio: $4.9B across 432 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR